Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.26 is 77% above its 5-year average of -1.13, near the high end of its 5-year range (-1.81–-0.26).
49.02% above its 12-month average of -0.51.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:42:44.210Z. Historical observations retain their original dates. Historical series through 2018-04-02.
EARNINGS PER SHARE (EPS)
-0.26
EARNINGS PER SHARE (EPS) AVG TTM
-0.51
EARNINGS PER SHARE (EPS) AVG 3Y
-0.97
EARNINGS PER SHARE (EPS) AVG 5Y
-1.13
EARNINGS PER SHARE (EPS) AVG 10Y
-2.03
EARNINGS PER SHARE (EPS) AVG 15Y
-266.85
EARNINGS PER SHARE (EPS) AVG 20Y
-1546.40
CURRENT VS TTM AVG
+49.02%
CURRENT VS 3Y AVG
+73.20%
CURRENT VS 5Y AVG
+76.92%
CURRENT VS 10Y AVG
+87.17%
CURRENT VS 15Y AVG
+99.90%
CURRENT VS 20Y AVG
+99.98%
Microbot Medical Inc.
Market Cap
$49.47M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.51
3Y Avg
-0.97
5Y Avg
-1.13
Market Cap
$49.20M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
Market Cap
$50.64M
Earnings Per Share (EPS)
-0.69
TTM Avg
-1.98
3Y Avg
-1.79
5Y Avg
-1.67
Market Cap
$50.86M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
-2.90
Market Cap
$48.05M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$47.64M
Earnings Per Share (EPS)
-9.11
TTM Avg
-2.23
3Y Avg
-1.64
5Y Avg
-3.32
Market Cap
$51.33M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$49.85M
Earnings Per Share (EPS)
N/A
TTM Avg
-30.18
3Y Avg
-88.49
5Y Avg
-66.35
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $49.47M | -0.26 | -0.51 | -0.97 | -1.13 |
| Clene Inc. (CLNN)vs › | $49.20M | -3.55 | -4.16 | -5.92 | -5.28 |
| biote Corp. (BTMD)vs › | $50.28M | 0.12 | 0.48 | 0.24 | 1.52 |
| INmune Bio, Inc. (INMB)vs › | $50.64M | -0.69 | -1.98 | -1.79 | -1.67 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $50.86M | -1.00 | -1.43 | -2.38 | -2.90 |
| Celularity Inc. (CELU)vs › | $48.05M | -2.83 | -3.12 | -4.06 | -22.86 |
| Lite Strategy, Inc. (LITS)vs › | $47.64M | -9.11 | -2.23 | -1.64 | -3.32 |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | -0.67 | -1.36 | -1.71 | -1.31 |
| Apollomics, Inc. (APLM)vs › | $49.85M | N/A | -30.18 | -88.49 | -66.35 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.20M | N/A | -7.29 | -67.66 | -178.24 |
Trailing EPS (TTM)
$-0.26
Forward EPS (Est.)
$-0.26
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.29 |
| 2024-12-31 | -0.73 |
| 2023-12-31 | -1.05 |
| 2022-12-31 | -1.81 |
| 2021-12-31 | -1.59 |
| 2020-12-31 | -1.29 |
| 2019-12-31 | -1.70 |
| 2018-12-31 | -0.81 |
| 2017-12-31 | -0.85 |
| 2016-12-31 | -10.14 |
| 2014-12-31 | -858.60 |
| 2013-12-31 | -986.43 |
| 2012-12-31 | -1603.80 |
| 2011-12-31 | -2430.00 |
| 2010-12-31 | -3321.00 |
| 2009-12-31 | -4050.00 |
| 2008-12-31 | -5670.00 |
| 2007-12-31 | -5022.00 |
| 2006-12-31 | -4050.00 |
| 2005-12-31 | -2916.00 |
| 2004-12-31 | -5006.63 |
| 2003-12-31 | -7290.00 |
| 2002-12-31 | -7452.00 |
| 2001-12-31 | -4050.00 |
| 2000-12-31 | -9396.00 |
| 1999-12-31 | -13608.00 |
| 1998-12-31 | -11178.00 |
| 1997-12-31 | -17496.00 |
| 1996-12-31 | -14418.00 |
